Turn Therapeutics Inc.
TTRX
$9.76
-$0.10-1.01%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -52.05% | -10.48% | -37.22% | 18.32% | 12.57% |
| Total Depreciation and Amortization | -12.40% | -15.16% | -11.29% | -6.82% | 15.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -420.79% | -608.08% | 48.97% | 9,832.81% | 106.49% |
| Change in Net Operating Assets | 432.60% | 88,900.00% | 220.76% | -251.49% | -244.19% |
| Cash from Operations | -181.99% | -88.26% | -40.15% | -24.80% | -3.78% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -76.92% | -21.81% | 8.87% | 35.06% | -22.40% |
| Cash from Investing | -80.94% | -69.75% | -35.67% | -25.32% | -48.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 142.45% | 313.92% | 235.54% | 500.98% | 395.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 586.36% | 500.38% | 576.49% | 1,201.43% | 395.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,687.44% | 1,463.00% | 399.66% | 317.81% | 154.50% |